Form 4: Weatherford International Director Steven Beringhause Reports Share Transactions
SEC Form 4 Filing
Director Steven Beringhause reports the vesting and partial cash settlement of restricted share units (RSUs) at Weatherford International.
Summary
- On January 18, 2025, Weatherford International Director Steven Beringhause reported transactions involving ordinary shares.
- 742 ordinary shares were acquired through the vesting of restricted share units (RSUs) granted on July 23, 2024, under the company's 2019 Equity Incentive Plan.
- The RSUs vested in full on January 18, 2025.
- 275 ordinary shares were disposed of at a price of $73.99 due to the partial cash settlement of the vested RSUs.
- Following these transactions, Beringhause directly owns 467 ordinary shares.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard reporting of insider transactions related to executive compensation.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of company directors and officers, which can provide insights into their confidence in the company's prospects.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation adjustments.
Key Dates
| Date | Description |
|---|---|
| July 23, 2024 | Date the restricted share units (RSUs) were granted. |
| January 18, 2025 | Date of the reported transactions, including vesting of RSUs and partial cash settlement. |
| January 22, 2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.